![]() |
市場調查報告書
商品編碼
1663673
膀胱鏡市場:各市場區隔規模,佔有率,法律規章,償付,介入,裝置率(用戶數),2036年為止的預測Cystoscopes Market Size by Segments, Share, Regulatory, Reimbursement, Interventions, Installed Base and Forecast to 2036 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
膀胱鏡是一種用於檢查和治療尿道和膀胱病變的儀器。對於泌尿道感染、血尿、失去膀胱控制、尿液樣本中的異常細胞、排尿疼痛、間質性膀胱炎、前列腺肥大引起的尿瀦留、尿道狹窄或存在結石、異常生長、息肉或癌症等症狀,建議進行膀胱鏡檢查。
膀胱鏡用於檢查和治療尿道和膀胱病變。
老年人口的增加是推動膀胱鏡市場成長的因素之一。隨著泌尿道感染的盛行率不斷上升以及老齡化社會中腎癌的發生率不斷上升,透過膀胱鏡檢查進行尿道診斷的情況日益增加。
本報告對全球膀胱鏡市場進行了詳細分析,包括競爭格局、 SWOT 分析、 2036 年市場預測、區域和國家趨勢。
Cystoscopes Market Size by Segments, Share, Regulatory, Reimbursement, Interventions, Installed Base and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Endoscopy Devices therapeutic area.
Cystoscope is a device used for examining and treating lesions of the urethra or bladder. A Cystoscope is recommended for the conditions such as urinary tract infections, blood in the urine, loss of bladder control, unusual cells found in urine sample, painful urination, interstitial cystitis, urinary blockage from prostate enlargement, narrowing and presence of stone in the urinary tract, unusual growth, polyp, and cancer.
Cystoscopes are used for examining and treating lesions of the urethra or bladder.
The increasing population of elderly patients is one of the factors contributing to the growing cystoscopy market. With the rising prevalence of urinary tract infections in the aging population and increasing rates of renal cancer, cystoscopy for urethra based diagnosis is on the rise.
Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with intervention volumes and installed base. The interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are -
Currently marketed Cystoscopes and evolving competitive landscape -
Global, Regional and Country level market specific insights -
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Olympus Corp, KARL STORZ SE & Co KG, PENTAX Medical Co, Stryker Corp, Richard Wolf GmbH, Laborie Medical Technologies Inc, Ambu A/S, NeoScope Inc, Coloplast A/S, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -